Meet Our Sponsors
Arenus® Animal Health is your source for quality, research-backed nutritional supplements for performance horses, including The Ultimate Digestive Aid- Assure® Guard Gold. Arenus also proudly offers Steadfast® Equine, Aleira®, Releira®, Eq-Well™ and Sore No-More® to support complete equine wellness.
Antech has developed new platforms to address health conditions of veterinary patients through diagnostics. Antech has partnered with Sound®, creator of NEXT Equine DR and SmartRLT Regenerative Laser, is the exclusive provider of GE Ultrasound and Samsung CT in the US veterinary market.
From fierce competitors to casual trail companions, horses require careful management to keep them at their best. As the global leader in equine health, Boehringer Ingelheim Equine Health’s focus and passion is to improve the lives of horses. For us, it’s all about the horse. It’s through heart-led science that we have developed the most advanced treatments in equine health. When you partner logic with passion and heart, you get better science. And better science means better care. We have pioneered advancements in the areas of equine asthma, gastric health, PPID, vaccines, joint therapy, parasite control, and many others through products such as Aservo® EquiHaler® (ciclesonide inhalation spray), Gastrogard® (omeprazole), Ulcergard® (omeprazole), Prascend® (pergolide tablets), Vetera® Vaccines, Surpass® (1% diclofenac sodium), Legend® (hyaluronate sodium) Injectable Solution, Equioxx® (firocoxib), and more. For more information about Boehringer Ingelheim, our product portfolio and our commitment to veterinary medicine, visit https://bi-animalhealth.com/equine/.
Contura Vet brings together bioengineering experience and veterinary expertise in the development of products for the treatment of osteoarthritis in animals. Headquartered in London, Contura Vet develops and produces hydrogel products in our state-of-the-art FDA- and GMP-approved facilities in Copenhagen, Denmark; the Contura Vet USA division was opened in Franklin, Tennessee in 2021.
Following success in human use with its unique, patented hydrogels, Contura International offers a new class of injectable joint therapy for the treatment of osteoarthritis (OA). Contura Vet was established in 2021 in the US to bring ArthramidVet® to market for the treatment of OA in horses and dogs. Since 2009, ArthramidVet has been used to treat non-infectious causes of joint lameness in animals, including both early and late stages of OA and degenerative joint disease (DJD). ArthramidVet is a 2.5% iPAAG hydrogel that, over the past 10 years, has been safely and successfully used in over 80,000 horses to treat all stages of arthritis – from early-stage synovitis to late-stage osteoarthritis and degenerative joint disease. For more
information, please visit www.ConturaVetUS.com.
Dechra’s equine portfolio includes Osphos® (clodronate injection), Orthokine® vet irap 10 and 60, and Osteokine® (PRP). Dechra also offers Equidone® Gel (domperidone), the Vetivex® line of parenteral fluids, Phycox® EQ joint health supplements, and a comprehensive line of topical dermatologic products. The recent addition of Zimeta® (dipyrone injection) further expands Dechra’s equine offerings.
Related Events
69th AAEP Annual Convention
All sessions are now available for purchase.
Virtual Wednesday Round Table: Acupuncture in Sport Horses
This content is an exclusive benefit for AAEP members. If you’re a…
Virtual Wednesday Round Table: Stress & Distress in Equine Medicine: A Path Towards Wellbeing
This content is an exclusive benefit for AAEP members. If you’re a…
